[1]
Flores, J.J. and Aguilera, E.P. 2026. New Therapies for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD/MASH): Clinical Outcomes and Implementation Challenges. Revista del Hospital Italiano de Buenos Aires. 46, 3 (Sep. 2026), e0001314. DOI:https://doi.org/10.51987/Rev.Hosp.Ital.B.Aires.v46i3.1314.